Gene: LYPLAL1
Official Full Name: lysophospholipase like 1provided by HGNC
Gene Summary: Enables palmitoyl-(protein) hydrolase activity. Involved in negative regulation of cGAS/STING signaling pathway. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27106 | LYPLAL1 Knockout cell line (HeLa) | Human | LYPLAL1 | 1:3~1:6 | Negative | Online Inquiry |
KO27107 | LYPLAL1 Knockout cell line (HCT 116) | Human | LYPLAL1 | 1:2~1:4 | Negative | Online Inquiry |
KO27108 | LYPLAL1 Knockout cell line (HEK293) | Human | LYPLAL1 | 1:3~1:6 | Negative | Online Inquiry |
KO27109 | LYPLAL1 Knockout cell line (A549) | Human | LYPLAL1 | 1:3~1:4 | Negative | Online Inquiry |
LYPLAL1 Gene Knockout Cell Lines represent a cutting-edge biological tool that enables researchers to investigate the functional roles of the LYPLAL1 gene in various physiological and pathological contexts. These specialized cell lines have been generated using CRISPR-Cas9 technology to achieve precise knockout of the LYPLAL1 gene, facilitating in-depth studies into its involvement in metabolic regulation, cellular signaling pathways, and disease mechanisms.
The key functions of LYPLAL1 knockout cell lines lie in their ability to elucidate gene function through gene editing. By knocking out the LYPLAL1 gene, researchers can evaluate the resultant phenotypic changes and assess downstream biological effects associated with disrupted lipid metabolism and inflammatory responses. This resource is particularly valuable for exploring therapeutic targets in conditions such as obesity, diabetes, and certain cancers where LYPLAL1 may play a crucial role.
Scientifically, these knockout cell lines hold immense importance in both research and clinical applications. They serve as critical models for drug discovery and compound screening, allowing for the identification of potential pharmacological agents that can modulate biological pathways influenced by LYPLAL1. Furthermore, their utility extends to basic research, particularly in genetic and cellular studies investigating the underlying mechanisms of disease.
In terms of advantages, LYPLAL1 Gene Knockout Cell Lines offer unparalleled specificity and efficiency compared to other gene deletion methods. The CRISPR-based approach ensures high fidelity in gene editing, leading to reproducible data and robust results. Unlike older techniques, this product minimizes off-target effects, thereby enhancing the reliability of experimental findings.
For researchers and clinicians alike, the value of LYPLAL1 Gene Knockout Cell Lines lies in their potential to drive innovations in biomedical research and therapeutic development. By providing a reliable platform for studying gene function, they open up new avenues for understanding complex biological systems and advancing precision medicine.
With a commitment to excellence in biotechnology, our company specializes in the development of high-quality, innovative biological products. We empower scientists with the necessary tools to unlock the complexities of genetic research, ensuring that they can achieve their research goals effectively and efficiently.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.